ArticleMedicine2026
Simplified versus traditional citrate anticoagulation in hemodialysis: Impact on clinical efficacy and patient prognosis, and correlative analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemodialysis (HD) is a critical therapy for patients with end-stage renal disease, and the choice of anticoagulation protocol is crucial for its success. The impact of simplified citrate anticoagulation that notably eliminates the need for calcium supplementation on clinical efficacy and patient prognosis in comparison to traditional citrate anticoagulation has not been comprehensively elucidated. This study aimed to assess the impact of different anticoagulation protocols on HD patients. A prospective cohort study was conducted involving 109 HD patients, comprising a traditional citrate anticoagulation group (n = 57) and a simplified citrate anticoagulation group (n = 52). Various clinical and prognostic parameters including coagulation, inflammatory markers, cardiovascular parameters, treatment response, and patient-reported outcomes were assessed. Correlative analyses were performed to explore the associations between different anticoagulation protocols and clinical and prognostic parameters. The simplified citrate anticoagulation group showed significantly prolonged activated partial thromboplastin time, higher levels of fibrinogen, interleukin-6, and white blood cell count compared to the traditional citrate anticoagulation group. The simplified citrate anticoagulation group also had a higher left ventricular ejection fraction, a higher rate of partial response (61.54% vs 31.58%), and a lower rate of stable disease (32.69% vs 63.16%). Additionally, the quality of life score was higher in the simplified citrate anticoagulation group. Correlative analysis revealed significant associations between the anticoagulation protocols and various clinical and prognostic parameters in HD patients. The simplified citrate anticoagulation protocol for HD demonstrates advantages across various domains, including coagulation parameters, inflammatory markers, cardiovascular parameters, treatment response, and patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.